KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.38 | 0.11 | -0.02 | -3.02 |
| FCF Yield | -1.82% | -4.07% | -2.66% | -2.07% |
| EV / EBITDA | -43.34 | -29.67 | -21.06 | -59.44 |
| Quality | ||||
| ROIC | -15.05% | -12.34% | -18.68% | -29.73% |
| Gross Margin | 50.63% | 45.69% | 44.29% | 43.39% |
| Cash Conversion Ratio | 0.56 | 1.02 | 0.46 | 0.84 |
| Growth | ||||
| Revenue 3-Year CAGR | 4,203,128.81% | 4,049,369.02% | 3,910,739.88% | 3,747,566.70% |
| Free Cash Flow Growth | 25.64% | -8.50% | -41.41% | 0.03% |
| Safety | ||||
| Net Debt / EBITDA | 6.06 | 9.07 | 4.08 | 0.43 |
| Interest Coverage | -16.70 | -15.10 | -27.39 | -11.55 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 1.46 | 1.42 |
| Cash Conversion Cycle | -121.72 | -115.91 | -120.82 | -159.81 |